9th May 2024 | Dublin, Ireland
This event serves as an invaluable platform for gaining comprehensive insights into the latest updates and strategies pertaining to EU GMP Annex 1 compliance, ensuring successful inspection readiness. It presents a unique opportunity to receive expert guidance on overcoming compliance challenges prevalent in the biopharmaceutical industry. Participants will have the privilege to engage and network with esteemed professionals and regulatory authorities, thereby broadening their professional horizons. The event also includes an exclusive tour of NIBRT’s state-of-the-art cell and gene facility, offering a glimpse into the forefront of biopharmaceutical research.
Don’t forget to visit our team on site!
NOTE
Please note that the event is now sold out. We appreciate your interest and encourage you to stay tuned for future events.
Our Team
Elizabeth Hunt
External Communications Manager
Jane Lyons
Country Manager
Ann-Marie Purcell
Commercial Manager
Patrick Nieuwenhuizen
Director, Principal Consultant
Noelle Clifford
Consultant
Louise Ui Fhatharta
Consultant
Zuzanna Gelnnon
Project Manager
Speaker Session
Speaker: Patrick Nieuwenhuizen, Principal Consultant
Topic: ATMP manufacturing and the relevance of Annex 1: Useful guidance to help ensuring a safe product
Time: 11:10– 11:45
Panel Discussion and attendee questions
Member: Patrick Nieuwenhuizen, Principal Consultant
Time: 14:40 – 15:15
